SPONSOR
Huahui Health
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 1, Phase 2, Phase 3
Conditions studied: Solid TumorNon-small Cell Lung CancerHepatocellular CarcinomaColorectal CancerHead and Neck Squamous Cell CarcinomaRenal Cell CarcinomaEndometrial CancerCervical CancerSmall-cell Lung CancerTriple Negative Breast Cancer
Huahui Health is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer.
The trial portfolio spans Phase 1, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Huahui Health
How many clinical trials has Huahui Health sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Huahui Health, of which 3 are actively recruiting participants. These trials cover conditions including Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Huahui Health research focus on?
Huahui Health clinical trials span Solid Tumor, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, and additional conditions. The research pipeline includes Phase 1, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Huahui Health clinical trial?
To participate in a Huahui Health trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Huahui Health trials with current recruitment status updated daily.
Clinical Trials by Huahui Health
NCT07623369 Phase 1
Recruiting
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Solid Tumor
NCT07547553 Phase 1, Phase 2
Recruiting
A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
Advanced or Unresectable Hepatocellular Carcinoma (HCC)
NCT07499544 Phase 3
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)
Chronic Hepatitis D Infection
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology